AdaptHealth (NASDAQ:AHCO) Stock Price Up 4%

Shares of AdaptHealth Corp. (NASDAQ:AHCO) traded up 4% during mid-day trading on Tuesday . The company traded as high as $11.02 and last traded at $10.97. 930,585 shares traded hands during mid-day trading, a decline of 12% from the average session volume of 1,063,141 shares. The stock had previously closed at $10.55.

Analyst Upgrades and Downgrades

A number of research firms recently commented on AHCO. Truist Financial reiterated a “buy” rating and set a $13.00 price objective on shares of AdaptHealth in a research report on Wednesday, May 15th. Royal Bank of Canada reiterated an “outperform” rating and issued a $13.00 price objective on shares of AdaptHealth in a research note on Monday, August 12th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, AdaptHealth presently has a consensus rating of “Hold” and a consensus target price of $10.70.

AdaptHealth Stock Up 2.5 %

The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.11 and a current ratio of 1.33. The company has a market capitalization of $1.44 billion, a PE ratio of -2.07, a price-to-earnings-growth ratio of 0.76 and a beta of 1.10. The company’s fifty day moving average is $10.38 and its 200-day moving average is $10.09.

AdaptHealth (NASDAQ:AHCO) last released its earnings results on Tuesday, August 6th. The company reported $0.13 EPS for the quarter, missing the consensus estimate of $0.19 by ($0.06). The company had revenue of $805.98 million during the quarter, compared to analysts’ expectations of $802.62 million. AdaptHealth had a positive return on equity of 8.47% and a negative net margin of 21.45%. AdaptHealth’s quarterly revenue was up 1.6% compared to the same quarter last year. During the same period last year, the firm posted $0.16 EPS. As a group, analysts predict that AdaptHealth Corp. will post 0.82 EPS for the current fiscal year.

Institutional Investors Weigh In On AdaptHealth

Several large investors have recently made changes to their positions in the company. GAMMA Investing LLC lifted its position in AdaptHealth by 197.1% during the first quarter. GAMMA Investing LLC now owns 2,537 shares of the company’s stock valued at $29,000 after purchasing an additional 1,683 shares during the last quarter. Covestor Ltd raised its position in AdaptHealth by 279.6% in the 1st quarter. Covestor Ltd now owns 3,109 shares of the company’s stock worth $36,000 after purchasing an additional 2,290 shares during the period. Canada Pension Plan Investment Board bought a new stake in AdaptHealth in the second quarter worth about $58,000. Blue Trust Inc. purchased a new position in shares of AdaptHealth during the second quarter valued at approximately $85,000. Finally, Innealta Capital LLC bought a new position in shares of AdaptHealth during the second quarter valued at approximately $101,000. 82.67% of the stock is owned by institutional investors.

About AdaptHealth

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.